Effects of albaconol from the basidiomycete Albatrellus confluens on DNA topoisomerase II-mediated DNA cleavage and relaxation

Planta Medica

Volumn 70, Issue 9, 2004, Pages 792-796

  Qing, Chen ^a   Liu, Ming Hua ^a   Yangl, Wei Min ^b   Zhang, Yan Li ^a   Wang, Lei ^a   Liu, Ji Kai ^b  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b KUNMING INSTITUTE OF BOTANY   (China)

Author keywords

Albaconol; Albatrellaceae; Albatrellus confluens; Antitumor activity; Topoisomerase

Indexed keywords

ALBACONOL; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); RESORCINOL; UNCLASSIFIED DRUG;

ALBATRELLUS CONFLUENS; ANTINEOPLASTIC ACTIVITY; ARTICLE; BASIDIOMYCETES; CANCER INHIBITION; CONTROLLED STUDY; DNA BINDING; DNA CLEAVAGE; DNA STRAND BREAKAGE; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MACROMOLECULE; TUMOR CELL LINE; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BASIDIOMYCOTA; BICYCLO COMPOUNDS; CELL LINE, TUMOR; DNA TOPOISOMERASES, TYPE II; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMANS; K562 CELLS; PHENOLS; PHYTOTHERAPY; PLANT EXTRACTS;

ALBATRELLACEAE; ALBATRELLUS; ALBATRELLUS CONFLUENS; BASIDIOMYCOTA; CONFLUENS;

EID: 5444248501     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-827224     Document Type: Article

References (19)

1. Ding ZH, Dong ZJ, Liu JK. Albaconol, a novel prenylated resorcinol (= benzene-I, 3-diol) from Basidiomycetes Albatrellus confluens. Helv Chim Acta 2001; 84: 259-62
2. Szallasi A, Biro T, Szabo T, Modarres S, Petersen M, Klusch A, Blumberg P, Krause JE, Sterner O. A non-pungent triprenyl phenol of fungal origin, scutigeral, stimulates rat dorsal root ganglion neurons via interaction at vanilloid receptors. Br J Pharmacol 1999; 126: 1351-8
3. Yang WM, Liu JK, Qing C, Liu YD, Ding ZH, Shen ZQ, Chen ZH. Albaconol from the mushroom Albatrellus confluens induces contraction and desensitization in Guinea pig. Planta Medica 2003; 69: 715-9
4. Kasahara K, Fujiwara Y, Sugimoto Y, Nishio K, Tamura T, Matsuda Tet al. Determinants of response to the DNA topoisomerase II inhibitors doxorubicin and etoposide in human lung cancer lines. J Natl Cancer Inst 1992; 84: 113-8
5. Hertzberg BP, Busby RW, Caranfa MJ, Holden KG, Johnson RK, Hecht SM et al. Irreversible trapping of the DNA-topoisomerase I covalent complex. Affinity labeling of the camptothecin binding site. J Biol Chem 1990; 265: 19287-95
6. Mosmman T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth 1983; 65: 55-63
7. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988; 48: 589-601
8. Zhou JJ, Yue XF, Han JX, Yang WY. Improved MTT assay for activity of antitumor agents. Chin J Pharm 1993; 24: 455-7
9. Sullivan DM, Glisson BS, Hodges PK, Smallwood-Kentro S, Rose WE. Proliferation dependence of topoisomerase II mediated drug action. Biochemistry 1986; 25: 2248-56
10. Peng Y, Bao DY, Wang LG, Liu XM, Ji XI. Effects of siwenmycin on DNA topoisomerases mediated strand cleavage and relaxation in vitro. J Chin Pharm Sci 1994; 3: 120-5
11. Liu XM, Wang LG, Ji XI. Determination of DNA topoisomerase II activity from mouse leukemia L121O cells, a target for screening antitumor agents. Cancer 1991; 10: 220-5
12. Chen AY, Liu LF. DNA topoisomerases: essential enzymes and lethal targets. Ann Pharmacol Toxicol 1994; 34: 191-218
13. Osheroff N. Biochemical basis for the interactions of type I and type II topoisomerases with DNA. Pharmacol Ther 1989; 41: 223-41
14. Gupta M, Fujimori A, Pommier Y. Eukaryotic DNA topoisomerase I. Biochim Biophys Acta 1995; 1262: 1-14
15. Capranico G, Binaschi M, Borgnetto ME, Zunino F, Palumbo M. A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisons. Trends Pharmacol Sci 1997; 18: 303-46
16. Froelich-Ammon SJ, Osheroff N. Topoisomerase poisons: Harnessing the dark side of enzyme mechanism. J Biol Chem 1995; 270: 21429-32
17. Wassermann K, Markovits J, Jaxel C, Capranico G, Kohn KW, Pommier Y et al. Effects of morpholinyl doxorubicins, doxorubicin and actinomycin D on mammalian DNA topoisomerases I and II. Mol Pharmacol 1990; 38: 38-45
18. Poddevin B, Riou JF, Lavelle F, Pommier Y. Dual topoisomerase I and II inhibition by intoplicine (RP-60 475), a new antitumor agent in early clinical trials. Mol Pharmacol 1993; 44: 767-74
19. Leteurtre F, Fujimori A, Tanizawa A, Chhabra A, Mazumder A, Kohlhage BG et al. Saintopin, a dual inhibitor of DNA topoisomerases I and II, as a probe for drug-enzyme interactions. J Biol Chem 1994; 269: 28702-7